What is a stock summary page? Click here for an overview.
Business Description
Synlogic Inc
NAICS : 325412
SIC : 2834
ISIN : US87166L1008
Description
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.3 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 1.13 | |||||
| Debt-to-EBITDA | -0.48 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -34.2 | |||||
| Beneish M-Score | -32.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -87.2 | |||||
| 3-Year EBITDA Growth Rate | 50.7 | |||||
| 3-Year EPS without NRI Growth Rate | 58.3 | |||||
| 3-Year FCF Growth Rate | 43.4 | |||||
| 3-Year Book Growth Rate | -67.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.4 | |||||
| 9-Day RSI | 43.83 | |||||
| 14-Day RSI | 44.33 | |||||
| 3-1 Month Momentum % | 2.94 | |||||
| 6-1 Month Momentum % | -8.5 | |||||
| 12-1 Month Momentum % | -21.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | |||||
| Quick Ratio | 2.8 | |||||
| Cash Ratio | 2.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -36 | |||||
| Shareholder Yield % | 26.82 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -197212.5 | |||||
| Net Margin % | -379787.5 | |||||
| FCF Margin % | -395900 | |||||
| ROE % | -172.75 | |||||
| ROA % | -87.4 | |||||
| ROIC % | -107.1 | |||||
| 3-Year ROIIC % | -111.8 | |||||
| ROC (Joel Greenblatt) % | -166.54 | |||||
| ROCE % | -135.35 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1280 | |||||
| PB Ratio | 1.17 | |||||
| Price-to-Tangible-Book | 1.17 | |||||
| EV-to-EBIT | 0.13 | |||||
| EV-to-EBITDA | 0.13 | |||||
| EV-to-Revenue | -486.13 | |||||
| EV-to-Forward-Revenue | 1.1 | |||||
| EV-to-FCF | 0.12 | |||||
| Price-to-GF-Value | 42.67 | |||||
| Price-to-Net-Current-Asset-Value | 1.17 | |||||
| Price-to-Net-Cash | 1.27 | |||||
| Earnings Yield (Greenblatt) % | 769.23 | |||||
| FCF Yield % | -211.56 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SYBX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Synlogic Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.008 | ||
| EPS (TTM) ($) | -2.51 | ||
| Beta | 0.59 | ||
| 3-Year Sharpe Ratio | -0.94 | ||
| 3-Year Sortino Ratio | -1.12 | ||
| Volatility % | 22.78 | ||
| 14-Day RSI | 44.33 | ||
| 14-Day ATR ($) | 0.060715 | ||
| 20-Day SMA ($) | 1.2942 | ||
| 12-1 Month Momentum % | -21.35 | ||
| 52-Week Range ($) | 1.15 - 1.96 | ||
| Shares Outstanding (Mil) | 11.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Synlogic Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Synlogic Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Synlogic Inc Frequently Asked Questions
What is Synlogic Inc(SYBX)'s stock price today?
The current price of SYBX is $1.28. The 52 week high of SYBX is $1.96 and 52 week low is $1.15.
When is next earnings date of Synlogic Inc(SYBX)?
The next earnings date of Synlogic Inc(SYBX) is 2025-05-14 Est..
Does Synlogic Inc(SYBX) pay dividends? If so, how much?
Synlogic Inc(SYBX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers